Thus, a strong correlation between expression of FRAT1 and the subcellular localisation of β-catenin indicates that FRAT1 may modulate the Wnt/β-catenin pathway in ovarian serous adenocarcinomas. The gene discussed is FRAT1; the disease is ovarian serous adenocarcinoma.